https://www.selleckchem.com/pr....oducts/epalrestat.ht
Two randomised controlled vaccination trials with artificial challenges were carried out in addition to a serological survey of levels of maternally derived antibodies (MDA) to parainfluenza type 3 virus (PI3V) and bovine respiratory syncytial virus (BRSV) in European calves. Ten-day-old calves with and without MDA were included in the two vaccine trials. Intranasal administration of a bivalent modified live (PI3V/BRSV) vaccine followed by artificial challenge approximately three months post vaccination. The study aimed to assess the
Like
Comment
Share
